Statistics for Aadi Bioscience, (id:5487 AADI)

Valuation metrics

Market cap

56.69M

Enterprise value

-5,476,946.00

Trailing P/E (ttm)

-0.94

Forward P/E

-2.28

PEG ratio

-2.28

Price/Sales (ttm)

2.26

Price/Book (mrq)

0.82

Enterprise Value/Revenue

-0.22

Enterprise Value/EBITDA

0.09

Overview

Shares outstanding

24.65M

Float

12.29M

Shares short

281.12K

% Held by insiders

0.10%

% Held by institutions

0.49%

Average volume (10 days)

146.05K

Average volume (90 days)

Price summary

52-Week low

1.21

52-Week high

5.70

52-Week change

-105.22%

Beta

0.37

50-Day moving average

2.02

200-Day moving average

1.85

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 27th, 2021

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-246.06%

Operating margin

-149.40%

Operational effectiveness

Return on assets

-35.27%

Return on equity

-65.95%

Income statement

Revenue (ttm)

0.93

Revenue per share (ttm)

0.93

Quarterly revenue growth (yoy)

Gross profit (ttm)

21.54M

EBITDA

-63,395,000.00

Net income to common (ttm)

-61,687,000.00

Diluted EPS (ttm)

-2.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

62.62M

Total cash per share (mrq)

2.54

Total debt (mrq)

946.00K

Total Debt/Equity (mrq)

1.37

Current ratio (mrq)

488.90%

Book value per share (mrq)

2.80

Cash flow

Cash flow statement

-54,141,000.00

Levered free cash flow (LFCF)

-35,620,500.00